NPI: 1174040034 · INDEPENDENCE, KY 41051 · Community/Behavioral Health Agency · NPI assigned 08/23/2017
Authorized official MCCORMAC, RUPERT controls 20+ related entities in our dataset. Read more
| Authorized Official | MCCORMAC, RUPERT (CHIEF EXECUTIVE OFFICER) |
| NPI Enumeration Date | 08/23/2017 |
Other providers sharing the same authorized official: MCCORMAC, RUPERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,022 | $35K |
| 2019 | 85,916 | $620K |
| 2020 | 41,101 | $1.21M |
| 2021 | 10,394 | $920K |
| 2022 | 11,030 | $756K |
| 2023 | 9,345 | $734K |
| 2024 | 5,897 | $531K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 66,538 | 11,110 | $3.76M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 72,443 | 3,980 | $497K |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | 2,291 | 1,911 | $136K |
| 99408 | 15,178 | 1,143 | $130K | |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 570 | 533 | $100K |
| H0033 | Oral medication administration, direct observation | 1,025 | 787 | $73K |
| 90832 | Psychotherapy, 30 minutes with patient | 3,265 | 1,188 | $48K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2,137 | 722 | $17K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 372 | 315 | $15K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 774 | 623 | $14K |
| 82075 | 850 | 735 | $7K | |
| 90791 | Psychiatric diagnostic evaluation | 165 | 105 | $3K |
| 99441 | 481 | 304 | $2K | |
| 90834 | Psychotherapy, 45 minutes with patient | 89 | 47 | $1K |
| 99406 | 264 | 215 | $1K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 67 | 59 | $469.77 |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14 | 12 | $350.45 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 66 | 59 | $186.42 |
| 80305 | 82 | 68 | $109.37 | |
| 86580 | 16 | 14 | $55.60 | |
| 36415 | Collection of venous blood by venipuncture | 18 | 14 | $34.18 |